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Abstract 
Background/Aim: Although it has been hypothesized that muscle metabolism and 
fatigability could be impaired in sickle cell patients, no study has addressed this issue. 
Methods: We compared muscle metabolism and function (muscle microvascular 
oxygenation, microvascular blood flow, muscle oxygen consumption and muscle 
microvascular oxygenation variability, which reflects vasomotion activity, maximal muscle 
force and local muscle fatigability) and the hemorheological profile at rest between 16 healthy 
subjects (AA), 20 sickle cell-hemoglobin C disease (SC) patients and 16 sickle cell anemia 
(SS) patients. Results: Muscle microvascular oxygenation was reduced in SS patients 
compared to the SC and AA groups and this reduction was not related to hemorhelogical 
abnormalities. No difference was observed between the three groups for oxygen consumption 
and vasomotion activity. Muscle microvascular blood flow was higher in SS patients 
compared to the AA group, and tended to be higher compared to the SC group. Multivariate 
analysis revealed that muscle oxygen consumption was independently associated with muscle 
microvascular blood flow in the two sickle cell groups (SC and SS). Finally, despite reduced 
muscle force in sickle cell patients, their local muscle fatigability was similar to that of the 
healthy subjects. Conclusions: Sickle cell patients have normal resting muscle oxygen 
consumption and fatigability despite hemorheological alterations and, for SS patients only, 
reduced muscle microvascular oxygenation and increased microvascular blood flow. Two 
alternative mechanisms can be proposed for SS patients: 1) the increased muscle 
microvascular blood flow is a way to compensate for the lower muscle microvascular 
oxygenation to maintain muscle oxygen consumption to normal values or 2) the reduced 
microvascular oxygenation coupled with a normal resting muscle oxygen consumption could 
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indicate that there is slight hypoxia within the muscle which is not sufficient to limit 
mitochondrial respiration but increases muscle microvascular blood flow. 
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Introduction 
Patients with sickle cell disease (SCD) are characterized by anemia and altered blood 
rheology which may impair blood flow [1], trigger vaso-occlusive crisis, cause tissue 
ischemia [2,3,4] and limit exercise capacity [5]. 
Few studies investigated baseline microvascular oxygenation at the cerebral level in SCD 
patients and reported reduced values suggesting a certain degree of chronic cerebral hypoxia 
[6,7,8]. But, it is unknown whether it is also the case in other organs. Callahan et al [9] 
previously suggested that muscle function could be altered in some patients with SCD. 
Moreover, it has been proposed [10] that reduced red blood cell (RBC) deformability in rat 
cremaster muscle could severely affects capillary recruitment and tissue oxygenation. Indeed, 
one may suggest that the reduced RBC deformability in SCD, in association with the other 
blood rheological abnormalities, could reduce muscle microcirculatory oxygenation, muscle 
oxygen consumption and impair muscle function in this population.  
 
However, Rodgers et al [11] previously reported high periodic microvascular blood flow 
oscillations at the skin level of sickle cell patients (i.e., high flowmotion and vasomotion 
activities) which might be helpful to maintain the microvascular blood flow despite the 
presence of hemorheological disturbances. Vasomotion is a form of spontaneous localized 
oscillations induced by spontaneous contraction and relaxation of the smooth muscle 
components in the small blood vessel walls which generate rhythmic changes in their 
diameter. Although vasomotion mechanisms are still under debate [12], several studies 
demonstrated that vasomotion may have beneficial effects on tissue oxygenation [13,14,15]. 
Therefore the hypothesis of a reduced muscle microvascular oxygenation in SCD patients, 
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due to abnormal hemorheology, compensated by a greater vasomotion activity needs to be 
tested.  
 
Because SCD patients are characterized by wide hemorheological disturbances, we 
hypothesized that muscle microvascular oxygenation (TOI), muscle oxygen consumption 
(VO2) and muscle function (i.e., maximal force and fatigability during a short local handgrip 
exercise) should be impaired in patients with sickle cell anemia (SS) or sickle cell-
hemoglobin C disease (SC) in comparison with a control group (AA). We also hypothesized 
that vasomotion activity could be greater in SCD patients in order to limit muscle VO2 
reduction. Since the level of VO2 is critical for tissue survival we tried to identify factors 
associated with local muscle VO2. We demonstrated that sickle cell patients have normal 
resting muscle oxygen consumption and fatigability despite hemorheological alterations and, 
for SS patients only, reduced muscle microvascular oxygenation.  
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Materials and methods 
Patients 
The study was approved by the Regional Ethics Committee (CPP Sud-Ouest Outre-Mer III, 
Bordeaux, France). The experiments were performed in accordance with the guidelines set by 
the Declaration of Helsinki. 
Fifty-two Guadeloupean volunteers (Table 1) participated in the study: 16 healthy subjects 
with no hemoglobinopathy (AA; 9 males and 7 females), 20 patients with sickle cell-
hemoglobin C disease (SC; 10 males and 10 females) and 16 patients with sickle cell anemia 
(SS; 8 males and 8 females).   
Both SS and SC patients recruited are regularly followed by the Sickle Cell Unit of the 
Academic Hospital of Pointe-à-Pitre (Pointe-à-Pitre, Guadeloupe). All participants were over 
18 yrs and were Afro-Caribbean native from Guadeloupe. SCD patients were in clinical 
steady state at the time of the study (i.e., without vaso-occlusive crisis, acute medical 
complication or blood transfusion/phlebotomies within the last 3 months). Exclusion criteria 
for all subjects were recent infectious episode (in the last month), ß-thalassemia, stroke or 
cerebral vasculopathy history, pregnancy or breast-feeding. Patients taking medication that 
could affect the hemorheological parameters studied, such as Hydroxyurea, were excluded. 
All participants received verbal and written explanation of the objectives and procedures of 
the study and subsequently provided written informed consent. 
 
Protocol 
For each participant, a physician from the Sickle Cell Unit (Guadeloupe) performed a clinical 
examination with transcutaneus oxygen saturation (SpO2) and blood pressure measurements. 
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The mean arterial pressure was calculated as follows: 1/3 systolic pressure + 2/3 diastolic 
pressure. Venous blood was sampled in EDTA tubes from the antecubital vein of the non-
dominant arm to perform hematological and hemorheological (i.e., blood viscosity, RBC 
deformability, RBC aggregation and disaggregation properties) measurements. Then, healthy 
subjects and SCD patients were placed in a normalized sitting position (thighs-trunk angle of 
110° and forearm at heart level to avoid venous pooling of the blood) for 10 min prior the 
near-infrared spectroscopy (NIRS, NIRO-200, Hamamatsu Photonics, Hamamatsu City, 
Japan) measurement. The experiment started with a 10-min muscle tissue oxygenation index 
(TOI) measurement at a sampling frequency of 6 Hz. At the end of this period, three 
consecutive venous occlusions (50 mmHg) of 30 seconds duration were applied to test 
microvascular forearm blood flow (mFBF) and muscle VO2. One minute of recovery 
separated each occlusion. Then, subjects performed handgrip exercise test to assess the 
maximum voluntary contraction (MVC) and local muscle fatigability. 
 
Near-infrared spectroscopy and determination of the muscle microvascular oxygenation 
(TOI), microvascular forearm blood flow (mFBF) and muscle oxygen consumption 
(VO2) 
NIRS techniques have been described elsewhere [16,17]. Briefly, NIRS principle is based on 
the relative transparency of tissue to light in the near-infrared region between 700 nm and 
1000 nm, and on the oxygen-dependent absorption changes of hemoglobin. NIRS can be used 
in sickle cell patients since the near-infrared spectra absorbance of hemoglobin S is similar to 
the one of normal hemoglobin [18].   
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The relative concentration changes of oxygenated hemoglobin (∆HbO2), deoxygenated 
hemoglobin (∆HHb), total hemoglobin (∆cHb) and tissue oxyhemoglobin saturation 
expressed as a tissue oxygenation index (TOI) were measured continuously and 
simultaneously throughout the experiment at the flexor digitorum superficialis muscle level 
using two channels of a three-wavelength (775 nm, 810 nm, 850 nm) high temporal resolution 
NIRS device (NIRO-200, Hamamatsu Photonics, Hamamatsu City, Japan). The center of the 
NIRS probes was placed on the flexor digitorum superficialis muscle at the proximal third of 
the forearm. The TOI is given by [∆HbO2 / (∆HHb + ∆HbO2)] x100. The TOI value reflects 
the microvascular oxygen saturation at the local region of muscle between emission and 
detection probes. The two probes were firmly attached on the flexor digitorum superficialis 
muscle with an inter-probes distance of 4 cm by means of a medical adhesive (Hamamatsu 
Photonics, Massy, France) for measurement of TOI, mFBF and VO2. 
 
Forearm measurements 
Adipose tissue thickness. Because adipose tissue thickness (i.e., skin + adipose tissue 
thickness) is known to affect near infrared spectrometer signals such as oxygenated 
hemoglobin (∆HbO2), deoxygenated hemoglobin (∆HHb) and total hemoglobin (∆cHb), 
attention was taken to recruit subjects with comparable skinfold thickness [19]. Skinfold 
thickness was measured between the near infrared spectrometer optodes using a skinfold 
caliper (Harpenden, West Sussex, U.K) and was divided by 2 to determine the adipose tissue 
thickness covering the flexor digitorum superficialis muscle. 
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mFBF. The sum of ∆HbO2 and ∆HHb reflects the total amount of hemoglobin (∆cHb), and 
changes in ∆cHb can be interpreted as changes in blood volume in the tissue [20]. As 
previously described, mFBF was calculated by evaluating the rate of increase in ∆cHb during 
venous occlusion [20] within the first seconds of the 30 seconds occlusion. The mFBF was 
averaged on the data obtained during the three venous occlusions [20]. However, because the 
hemoglobin concentration is very different between AA, SC and SS groups, we normalized 
mFBF by dividing the rate of increase in ∆cHb by the hemoglobin concentration for each 
participant. Normalized concentration changes of ∆cHb were expressed in ∆µmol.cm.dL.min-
1.
g
-1
. 
VO2. Muscle VO2 was determined by measuring the rate of increase in ∆HHb within the first 
seconds of the 30 seconds occlusion [20]. Concentration changes of ∆HHb were expressed in 
∆µmol.cm.min-1. Mean muscle VO2 was averaged on the data obtained during the three 
venous occlusions. The venous occlusion method for muscle VO2 measurements used in this 
study is less reliable than the arterial occlusion method [20]. However, since a short 
ischemia/hypoxia episode may promote the polymerization of hemoglobin S (HbS) and RBC 
sickling, hence increasing the risk for a painful vaso-occlusive crisis to occur, we used the 
venous occlusion method.  
 
Muscle force and fatigability 
To test muscle function, maximum voluntary contraction (MVC) force was determined by 3 
consecutive MVC interspaced with one-minute recovery. The higher value was considered as 
being the MVC force (pre-MVC). After a recovery period of 5 min, the subject was asked to 
10 
 
perform six intermittent isometric handgrip contraction (5 seconds at 50% MVC) followed by 
5 seconds at rest. This protocol is adapted from Hamaoka and colleagues [21]. Ten seconds 
after the sixth isometric contraction, MVC force was re-determined once (post-MVC). To 
control the quality of MVC, the root mean square (RMS) obtained with surface 
electromyography (EMG) was used. The post-MCV was considered maximal only if the RMS 
of the post-MVC was equal or slightly higher than the RMS of the pre-MVC. This condition 
was fulfilled for 8 AA subjects, 7 SC and 8 SS patients and statistical analysis of local 
exercise data was performed on these subgroups. 
 
Surface electromyography (EMG) activity 
EMG from the flexor digitorum superficialis muscle was recorded by means of bipolar 
Ag/AgCl electrodes (Red Dot
TM
, Saint Paul, Canada) with a diameter of 9 mm and an inter-
electrode distance of 20 mm. The electrodes were placed on the flexor digitorum superficialis 
muscle distally after the near infrared spectrometer probes. The reference electrode was 
placed on the patella. In order to minimize movement artifacts, electrodes and cables were 
strapped on the subjects using medical hypoallergenic tape. EMG activity was recorded 
continuously during the exercise cession via a dedicated acquisition system (MP30, Biopac 
Systems, Santa Barbara, CA, USA). The EMG signals were amplified (1000x), band-pass 
filtered (30-500 Hz) and sampled at 1000 Hz. The EMG signal amplitude was quantified by 
the calculation of the RMS. The RMS was calculated over a 1 second period around the 
maximal value for the MVC (Table 2). 
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Spectral analysis of muscle microvascular oxygenation variability 
Muscle microvascular blood flow is variable across the time for a given subject and this 
variability reflects muscle microvascular flowmotion and vasomotion. In resting condition, 
the TOI variability mainly reflects blood flow variability since muscle oxygen consumption is 
constant over the time [22,23]. Muscle microcirculatory oxygenation exhibits spontaneous 
oscillations in five frequency components [22,23]. The Fast Fourier Transform (Welch’s 
periodogram method) was applied on the TOI signal for the evaluation of the total power of 
the spectrum in the frequency interval 0.005-2 Hz (i.e., total muscle microcirculatory 
oxygenation variability) and calculation of the power across 5 band frequencies. The upper 
limit of 2 Hz was set to include the heart rate frequency, while the lower limit was chosen to 
include the three lowest frequencies intervals usually observed in tissue oxygenation signals 
[22,23,24]. It has been demonstrated that interval I (0.005-0.02 Hz) reflects nitric oxide 
metabolism and/or endothelial function [25,26,27], interval II (0.02-0.06 Hz) depends on the 
sympathetic activity of the vessel wall [23], and interval III (0.06-0.20 Hz) corresponds to the 
myogenic activity [26], For the high oscillatory activities, interval IV (0.20-0.6 Hz) depends 
on the breathing frequency and interval V (0.6-2 Hz) is under the influence of heart rate and 
cardiac output [22]. The whole oscillations recorded (i.e., TOI variability or total power of the 
spectrum) reflect flowmotion. The flowmotion results from the motion of the blood cells and 
their interaction with the vessel walls. The low frequency domain (intervals I, II and III) 
corresponds to the vasomotion activity [22,23]. The power of each interval was also analyzed 
and expressed in percent contribution of the total power of TOI variability. 
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Hematological parameters 
Hematocrit was measured after blood microcentrifugation at 9500 g for 10 min (JOUAN-
HEMA-C, Saint Herblain, France). Total counts of leukocytes, platelets and RBCs, 
percentage of reticulocytes and hemoglobin concentration were determined using a 
hematology analyzer (Max M-Retic, Coulter, USA).  
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Hemorheological parameters measurement 
Hemorheological parameters were measured within the four hours after sampling and after 
full re-oxygenation of blood for 10-15 min [28]. Blood viscosity was measured at ≈ 25°C and 
native hematocrit using a cone-plate viscometer (Brookfield DVII+ with CPE40 spindle) at 
225 s
-1
. The RBC elongation index values were determined at 30 Pa by laser diffraction 
analysis (ecktacytometry) and at 37°C, using the Laser assisted Optical Rotational Cell 
Analyzer (LORCA, RR Mechatronics, Hoorn, The Netherlands). The system calculates an 
average RBC elongation index. The higher this index, the more deformable the RBCs. RBC 
aggregation was determined at 37°C via syllectometry (i.e., laser backscatter versus time), 
using the LORCA (RR Mechtronics, Hoom, The Netherlands), after adjustment of hematocrit 
to 40%. The system calculates an aggregation index. The RBC disaggregation threshold (i.e., 
the minimal shear rate needed to prevent RBC aggregation or to break down existing RBC 
aggregates) was determined using a re-iteration procedure [29]. The RBC disaggregation 
threshold mainly reflects the RBC aggregate strength while the RBC aggregation index is a 
measure of the extent of aggregation integrated during a time period of 2 minutes. 
Hemorheological measurements were performed according to the international guidelines for 
hemorheological laboratory techniques [28]. 
 
Statistics 
All values were expressed as means ± standard deviations. The data were tested for the 
normality (Kolmogorov-Smirnov test) and homogeneity of variance (Levene test). 
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Physiological, hematological, hemorheological and muscle oxygenation parameters were 
compared between the three groups using a one-way analysis of variance (ANOVA) followed 
by a Newman-Keuls post-hoc test. When the rules for parametric test application were not 
fulfilled, a Kruskal-Wallis test followed by Dunn’s multiple comparison tests was used.  
To identify factors associated with muscle VO2 (i.e., dependent variable) in AA, SC or SS 
subjects, we used parametric or non parametric correlations (Pearson or Spearman, 
respectively) between muscle VO2 and the others physiological/biological parameters. Then 
all variables at p < 0.2 were included in a multivariate linear regression models to identify the 
covariates independently associated with muscle VO2. The significance level was defined as p 
< 0.05. Analyses were conducted using SPSS (v. 20, IBM SPSS Statistics, Chicago, IL). 
 
Results 
Subjects’ characteristics, hematological and hemorheological parameters 
The subjects’ characteristics, hematological and hemorheological parameters are summarized 
in the Table 1.  
Age, mean arterial pressure and skin + adipose tissue thickness were not significantly 
different between the three groups. SpO2 was lower in the SS group compared to both AA and 
SC groups. 
Fetal hemoglobin level, leukocytes and percentage of reticulocytes were significantly higher 
in the SS group than in both SC and AA groups. RBC count was significantly lower in the SS 
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group compared to the SC and AA groups. Hemoglobin and hematocrit were different 
between the three groups with AA > SC > SS. The platelets count was higher in the SS group 
than in the AA group and no difference was observed between SC patients and AA subjects or 
SS patients.  
Blood viscosity was greater in the SC group than in the AA and SS groups. The SS and AA 
groups were not significantly different regarding blood viscosity. RBC elongation index was 
significantly different between the three groups in the following order: SS < SC < AA. The 
RBC aggregation index was different between the three groups such as SC < SS < AA. The 
RBC disaggregation threshold was higher in the two SCD groups in comparison with AA 
subjects.  
 
Muscle microvascular oxygenation (TOI), microvascular forearm blood flow (mFBF) 
and muscle oxygen consumption (VO2)  
The muscle TOI (Figure 1) was lower in SS group compared to both AA and SC groups and 
this was not related to the degree of hemorheological alterations as no significant correlation 
was found between muscle TOI and hemorheological parameters. mFBF was significantly 
higher in the SS group than in the AA group, and tended to be higher compared to the SC 
group (Figure 2a). No statistical difference was observed between the three groups for muscle 
VO2 (Figure 2b). 
 
Muscle TOI variability 
The total muscle TOI variability (Figure 3a), the power spectral density for the intervals I, II, 
III representing vasomotion activity (Figure 3b) and the power spectral density for the 
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intervals IV and V (Figure 3c) were not different between the groups. The relative 
contributions of intervals I, II, III and IV were not different between the three groups (Figure 
3d). The relative contribution of the interval V characterizing the effect of cardiac output on 
TOI variability was increased in the SS group in comparison with AA and SC groups (SS > 
SC = AA) (Figure 3d). A representative example of Fast Fourier Transform analysis of the 
TOI signal variability in three subjects (1 AA, 1 SC and 1 SS patient) is shown on Figure 4. 
 
Muscle VO2 correlations and multivariate linear regression models 
In the AA group, muscle VO2 was negatively correlated with TOI (r = -0.7; p < 0.01) and 
adipose tissue thickness (r = -0.61; p = 0.01), positively correlated with vasomotion activity 
(i.e., TOI variability of interval I + II + III; r = 0.69; p < 0.01) and tended to be positively 
correlated with hemoglobin concentration (r = 0.45; p = 0.08). No correlation was observed 
between muscle VO2 and SpO2, mFBF or hemorheological parameters in the AA group. To 
identify factors independently associated with muscle VO2, a multivariate linear regression 
analysis was performed. The multivariate linear regression model included muscle VO2 as 
dependent variable and hemoglobin concentration, TOI, adipose tissue thickness and 
vasomotion activity as covariates. The overall model was statistically significant (R² = 0.64; p 
= 0.015) and only TOI remained significantly associated with the muscle VO2 (beta = -0.62; p 
= 0.045). 
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In the SC group, muscle VO2 was positively correlated with mFBF (r= 0.77; p < 0.001) and 
vasomotion activity (r = 0.71; p < 0.001), negatively correlated with the RBC disaggregation 
threshold (r = -0.52; p < 0.05) and adipose tissue thickness (r = -0.741; p < 0.001), and tended 
to be negatively correlated with TOI (r = - 0.43; p = 0.06). Because the p value was less than 
0.20 between RBC aggregation index and muscle VO2 (p = 0.16), RBC aggregation index 
was included in the multivariate linear regression analysis with TOI, mFBF, RBC 
disaggregation threshold, adipose tissue thickness and vasomotion activity as covariates, and 
muscle VO2 as dependent variable. The overall model was highly statistically significant 
demonstrating that these variables together account for almost 90% of the variation in muscle 
VO2 (R² = 0.89; p < 0.001). Among these variables, adipose tissue thickness (beta = -0.56; p = 
0.01), mFBF (beta = 0.39; p = 0.03) and the RBC disaggregation threshold (beta = -0.55; p = 
0.03) remained significantly and independently associated with the muscle VO2. 
 
For the SS group, we observed a positive correlation between VO2 and mFBF (r = 0.67; p < 
0.01). No correlation was observed between muscle VO2 and the other parameters but both 
RBC elongation index (p = 0.11) and RBC aggregation index (p = 0.13) were included with 
mFBF as covariates in the multivariate linear regression model to test the independent 
association with muscle VO2. The overall model was statistically significant (R² = 0.47; p = 
0.048) and only mFBF remained significantly associated with the muscle VO2 (beta = 0.73; p 
= 0.03). 
 
Muscle force and fatigability 
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Muscle force and fatigability are summarized in the Table 2. The pre-MVC values were lower 
in SC and SS groups compared to the AA group. The post-MVC values were lower in the SS 
group compared to the AA group. Although the post-MVC values were not statistically 
different between the SC and AA groups, they tended to be lower in the SC patients (p = 
0.07). In each of the three groups pre-MVC values were significantly higher than post-MCV 
values. No difference was observed between the three groups for the RMS pre-MVC and 
post-MCV. Nevertheless, the two sickle cell groups tended to have a higher RMS pre-MVC 
than the AA group (p = 0.1). RMS pre-MVC and RMS post-MVC were not different. No 
difference was observed between the three groups for the percent of force decrease between 
pre-MVC and post-MCV.  
 
Discussion 
 
This is the first study investigating muscle microvascular metabolism in the sickle cell 
population. We demonstrated 1) normal muscle microvascular oxygenation in SC patients but 
reduced muscle microvascular oxygenation in SS patients when compared with AA control 
subjects; 2) no difference between AA, SC and SS subjects regarding muscle oxygen 
consumption or vasomotion activity despite the presence of hemorheological abnormalities in 
the sickle cell population; 3) muscle microvascular blood flow was significantly higher in the 
SS group compared to the AA group, and tended to be higher compared with SC patients; 4) a 
significant association between muscle oxygen consumption and muscle microvascular blood 
flow in SC and SS patients (and with the RBC disaggregation threshold in SC patients only), 
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whereas muscle oxygen consumption is dependent on muscle microvascular oxygenation in 
AA control subjects. Local exercise challenge showed 1) a reduced forearm maximal 
voluntary contraction in SS and SC patients compared to the AA group; 2) similar force 
decrement after an intermittent handgrip exercise in the three groups.  
 
Hemorheological parameters 
The observed blood rheological abnormalities of SC and SS groups were in agreement with 
previous studies [30,31], with RBC deformability and aggregation being reduced and the 
RBC disaggregation threshold (i.e., the strength to separate RBC aggregates) being 
abnormally elevated in the SCD patients in comparison with the control subjects. In non-SCD 
context, it has been demonstrated that hemorheological abnormalities may alter blood flow in 
macro- and microcirculation, as well as tissue oxygenation [10,32,33]. However, the present 
study showed that the reduction of muscle microvascular oxygenation in the SS group was not 
associated with the degree of hemorheological alterations. Moreover, despite the presence of 
blood hyperviscosity in SC patients, this group had normal muscle microvascular 
oxygenation. These findings suggest that the muscle microvascular system at rest may adapt 
to compensate for the RBC rheological disorders and to provide enough oxygen to muscle 
tissue.  
 
Methodological considerations and limitations 
We found no correlation between adipose tissue thickness and muscle microvascular 
oxygenation and microvascular blood flow. In contrast, a significant correlation was found 
between adipose tissue thickness and muscle oxygen consumption in AA and SC groups but 
not in the SS group. Because adipose tissue thickness is a substantial confounder in the 
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measurement of near-infrared parameters, muscle oxygen consumption could have been 
underestimated in the AA and SC groups. Nevertheless, in this experiment, attention was 
devoted to make the skinfold thickness very comparable between the three groups. The mean 
difference between the groups for adipose tissue thickness was 0.1-0.4 mm and was not 
significant. It was previously shown that the near-infrared light absorbance was decreased of 
30 % when the thickness of the fat layer increased from 2.5 to 5 mm [19]. We believe that the 
small difference of adipose tissue thickness between our groups had a limited influence on the 
mean muscle oxygen consumption of AA and SC groups. Nevertheless, because the value of 
the adipose tissue thickness ranged from ~1.4 to 6.7 mm in each group, this parameter was 
considered in the multivariate linear regressions models to identify factors associated with the 
local muscle VO2 within AA and SC groups. We reported that adipose tissue thickness 
remained independently associated with muscle oxygen consumption in the SC group, only.  
 
Unfortunately, we were not able to normalize the muscle oxygen consumption by the muscle 
mass. It may be a limit of the study since a greater number of muscle cells will increase the 
value of resting muscle oxygen consumption. Nevertheless, it has been clearly demonstrated 
that SS patient have usually lower lean and fat mass than healthy subjects [34,35] because of 
an increased rate of protein turnover [35]. Badallo et al [36] suggested that this higher protein 
turnover rate could also occur at the muscle level in SS patients. A lower muscle mass in 
sickle cell patients could result in a greater muscle VO2 in SS patients compared to the AA 
and SC groups. Nevertheless, it is also possible that NIRS signal could be poorly affected by 
muscle mass since only a limited proportion of the whole muscle size is analyzed: the spatial 
resolution of the NIRS signal is limited at approximately the half of the interprobes distance 
(i.e., ~2 cm) [19]. The impact of muscle mass on muscle oxygen consumption measurement 
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using NIRS device is probably not linear and specific designed protocols to address these 
issues are needed.  
 
Muscle microvascular metabolism 
Despite reduced muscle microvascular oxygenation (in SS group only) and hemorheological 
alterations, the muscle oxygen consumption in SC and SS patients was not different from the 
AA group. One may hypothesize that muscle oxygen extraction could be increased in SS 
patients. The reduced affinity of hemoglobin S for oxygen at low oxygen partial pressure [37] 
could facilitate the delivery of oxygen to the tissues, thus decreasing muscle microvascular 
oxygenation but maintaining muscle oxygen consumption to normal level. But, it could also 
be argued that the reduced affinity of hemoglobin S for oxygen could be offset by an impaired 
oxygen loading in the lung capillaries. However, although a significant amount of sickle cells 
(the more dense) are not able to load oxygen as well as than discoid sickle cells [37], the 
hemoglobin oxygen saturation of the SS group was only modestly decreased. In addition, no 
correlation between muscle oxygenation or muscle oxygen consumption and arterial 
hemoglobin oxygen saturation was observed in our study.  
 
The reduction of the muscle microvascular oxygenation in SS patients could be at the origin 
of the increased muscle blood flow in this group since a decrease of the arterial oxygen 
content usually results in a rise of blood flow [38]. Ellsworth et al. suggested that RBCs are 
able to detect a reduction of the hemoglobin oxygen saturation and, in turn, release ATP into 
the circulation to cause vasodilation and increase blood flow [39]. In addition, one could 
suggest that the reduced microvascular oxygenation could lower the muscle oxygen 
consumption leading to an increased glycolytic end-products production, such as adenosine, 
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causing the relaxation of vascular smooth muscle cells and vasodilation [40]. Indeed, the 
increased muscle microvascular blood flow in SS patients could serve to maintain muscle 
oxygen consumption to normal level. However, another mechanism can be proposed. The 
reduced microvascular oxygenation coupled with a normal resting muscle oxygen 
consumption could indicate that there is slight hypoxia within the muscle which is not 
sufficient to limit mitochondrial respiration (because of high affinity of cytochrome c oxidase 
for oxygen) [41]; and 2) the increased microvascular blood flow is a consequence of the slight 
hypoxia, which would serve to partially reverse the hypoxia, without affecting muscle oxygen 
consumption, because even moderate hypoxia does not limit resting respiration rate [41].  
 
In the SC group, an independent association was also observed between muscle oxygen 
consumption and the RBC disaggregation threshold. The elevated RBC disaggregation 
threshold in SC patients may increase flow resistance at the entry of capillaries where RBCs 
aggregates need to be fully dispersed before they can be able of entering into, and negotiate, 
small capillaries [32]. Indeed, high RBC disaggregation threshold could impair muscle 
perfusion and muscle oxygen consumption. The reasons why this association was observed in 
the SC group and not in the SS group, despite a comparable RBC disaggregation threshold in 
the two groups, are unknown. But, one may hypothesize that the higher microvascular blood 
flow observed in SS patients could break-down the existing RBC aggregates more easily than 
in SC patients, hence limiting the impact of the elevated RBC disaggregation threshold on the 
microcirculation of SS patients at the muscle level.  
 
Although vasomotion was positively correlated with muscle oxygen consumption in SC 
patients (but not in SS patient), the multivariate linear regression failed to demonstrate an 
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independent association between these two parameters. Vasomotion activity is known to be 
less pronounced in muscle than in other organs such as brain or kidneys where vasomotion is 
a key regulator of tissue perfusion [40]. Our results suggest that muscle microvascular blood 
flow is more effective than muscle vasomotion activity to maintain normal resting muscle 
oxygen consumption in sickle cell patients.  
We did not address the role of the autonomic nervous system activity, and more particularly 
of the sympathetic activity, on the muscle blood flow regulation in this study. It is known that 
sickle cell patients (mainly SS patients) are characterized by an autonomic imbalance with a 
loss of heart rate variability [3,42]. Whether this autonomic imbalance impacts on the 
regulation of the baseline muscle blood flow in this population is unknown. Nevertheless, the 
results obtained with the spectral analysis of the NIRS signal demonstrates that interval II 
(figures 3b and 3d), which depends on the sympathetic activity of the vessel wall, did not 
differ between SS patients and the two other groups. Indeed, it is highly possible that local 
vasodilatory substances released by muscles or RBCs have played a role in the positive 
regulation of muscle blood flow. 
 
Muscle force and fatigability 
The short and local handgrip exercise demonstrated a reduction of the maximal voluntary 
muscle force in SS and SC patients compared to AA group. This result is in accordance with 
the literature [43]. Although the RMS values of the pre-maximum voluntary contraction were 
not significantly different between the three groups, they tended to be lower in sickle cell 
patients compared to the control group (p = 0.1). RMS is an indicator of the spatial and 
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temporal muscle fibers recruitment [44]. Therefore the reduction of the maximal voluntary 
muscle force in SS and SC patients may be attributable to a lower muscle mass or neural 
recruitment that could be due to strength deconditionning and physical inactivity. In contrast, 
the decrease of force after the intermittent handgrip exercise was not different between the 
three groups suggesting that local muscle fatigability is similar in patients and control 
subjects. The normal muscle metabolism and the normal or higher local microvascular blood 
flow observed in sickle cell patients probably participate in maintaining a normal muscle 
function during a local submaximal exercise. Nevertheless, the microvascular adaptations 
observed at rest could be of limited impact in SCD patients during longer or more intense 
physical efforts since the important cardio-respiratory work is not sufficient to compensate for 
the adverse effects of anemia on tissue oxygen delivery during intense exercise [9,30,45].  
 
In conclusion, we demonstrated that sickle cell patients have normal baseline muscle oxygen 
consumption despite hemorheological alterations and that only SS patients had reduced 
muscle microvascular oxygenation and increased microvascular blood flow. The increased 
muscle microvascular blood flow in SS patients could be either a way to compensate for the 
reduced muscle microvascular oxygenation, hence maintaining muscle oxygen consumption 
to normal level or a consequence of a slight hypoxia within the muscle, which is not sufficient 
to limit the muscle oxygen consumption. Altogether, these results suggest that the limited 
maximal exercise capacity in sickle cell patients is rather due to chronic anemia, 
cardiorespiratory over-solicitation and/or physical inactivity than muscle metabolism 
alterations. However, further studies are needed to characterize muscle metabolism at exercise 
and in most severe patients. 
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Figure Legends 
 
Fig 1. Muscle microvascular oxygen saturation (TOI) at rest in AA, SC and SS groups. 
Different from AA group (
*
p < 0.05); different from SC group (
†
p < 0.05).  
 
Fig 2. Forearm blood flow at rest (2a) and muscle oxygen consumption at rest (2b) in 
AA, SC and SS groups.  
 
Fig 3. Fast Fourier Transform analysis of TOI signal variability. Total power spectral 
density (3a, flowmotion activity), power spectral density in interval I, II and III (3b, 
vasomotion activity), power spectral density in interval IV, V (3c) and normalized spectral 
density (3d). Interval I = endothelial activity and/or nitric oxide metabolism, interval II = 
nervous sympathetic activity of the vessel wall, interval III = myogenic activity, interval IV = 
breathing frequency and interval V heart rate and cardiac output.  
 
Fig 4. Example of Fast Fourier Transform analysis of TOI signal variability in one AA 
subject (left), one SC patient (middle) and one SS patient (right). The frequency axis is 
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divided into three parts: vasomotion activity (left), interval IV (middle), and interval V (right). 
Note that the scale of the Y-axis is different for the three subjects. 
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Table 1. Subjects characteristics, hematological and hemorheological parameters in healthy 
subjects (AA) and patients with sickle cell-hemoglobin C disease (SC) or sickle cell anemia 
(SS)  
 AA SC SS 
Age (yrs) 34.6 ± 12.5 35.5 ± 12.3 32.9 ± 13.5 
MAP (mmHg) 90.8 ± 9.2 88.9 ± 11.9 84.8 ± 8.3 
SpO2 (%) 99.6 ± 0.7 99.2 ± 1.0 95.8 ± 3.0
†*
 
SATT (mm) 3.2 ± 1.0 3.1 ± 1.3 2.8 ± 1.4 
Fetal hemoglobin (%) 0.4 ± 0.6 1.2 ± 0.8 6.8 ± 5.6
*†
 
Hemoglobin S (%) - 47.4 ± 0.9 83.8 ± 6.1
*
 
Hemoglobin C (%) - 43.4 ± 1.3 - 
Leukocytes (10
9
/L) 6.3 ± 2.1 7.4 ± 2.5 11.3 ± 3.2
*†
 
Red blood cells (10
12
/L) 4.60 ± 0.52 4.35 ± 0.80 2.88 ± 0.43
*†
 
Hemoglobin (g/dL) 13.5 ± 1.3 11.1 ± 1.2
*
 8.4 ± 1.1
*†
 
Hematocrit (%) 42.0 ± 3.4 32.5 ± 2.8
*
 24.9 ± 4.3
*†
 
Reticulocytes (%) 1.1 ± 0.5 2.5 ± 1.6 8.4 ± 3.3
*†
 
Platelets count (10
9
/L) 248 ± 58 311 ± 171 403 ± 119
*
 
çb at 225s
-1
 (mPa/s) 6.3 ± 1.0 7.9 ± 1.2
*
 6.3 ± 1.6
†
 
EI at 30 Pa 0.59 ± 0.02 0.43 ± 0.05
*
 0.34 ± 0.12
*†
 
RBC aggregation index (%) 64.6 ± 7.2 43.2 ± 9.4
*
 52.5 ± 10.6
*†
 
RBC disaggregation threshold (s
-1
) 146 ± 43 295 ± 128
*
 394 ± 172
*
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Values represent mean ± S.D. MAP = mean arterial pressure, SpO2 = transcutaneus oxygen 
saturation, SATT = skin + adipose tissue thickness, çb = blood viscosity, EI = Elongation 
Index (i.e., RBC deformability). Different from AA (
*
p < 0.05); different from SC (
†
p < 0.05). 
 
Table 2. Muscle force and fatigability (i.e., force decrease) in healthy subjects (AA) and 
patients with sickle cell-hemoglobin C disease (SC) patients or sickle cell anemia (SS).  
 AA SC SS 
n (M/F) 8 (3/5) 7 (3/4) 8 (3/5) 
Pre-MVC (Kg) 18.2 ± 3.0 14.9 ± 3.5* 13.2 ± 2.5* 
RMS pre-MVC (mV) 0.60 ± 0.26 0.46 ± 0.10 0.35 ± 0.10 
Post-MVC (Kg) 14.4 ± 3.0† 12.0 ± 2.3† 11.1 ± 1.8*† 
RMS post-MVC (mV) 0.64 ± 0.30 0.46 ± 0.10 0.39 ± 0.10 
Force decrease (%) 22.0 ± 6.0 18.4 ± 4.4 17.2 ± 7.7 
Values represent mean ± S.D. n (M/F) = sample size (male/female), pre-MVC = maximal 
voluntary contraction before isometric handgrip exercise, post-MVC = maximal voluntary 
contraction after isometric handgrip exercise, force decrease = percentage of maximal 
voluntary contraction decrease after exercise, RMS = root mean square. Post-MVC of SC 
patients tended to be lower than AA subjects (p = 0.07).  Different from AA group (
*
p < 
0.05); different from pre-MVC (
†
p < 0.05). 
